BELATACEPT

Approval Year

Show entries

Name

Type

Language

NULOJIX

Preferred Name

English

BELATACEPT

Official Name

English

BELATACEPT [PURPLE BOOK CDER]

Common Name

English

BELATACEPT [MART.]

Common Name

English

CTLA-4 (ANTIGEN) (29-TYROSINE,104-GLUTAMIC ACID) (HUMAN EXTRACELLULAR DOMAIN-CONTAINING FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN MONOCLONAL FC DOMAIN-CONTAINING FRAGMENT), BIMOL. (120->120')-DISULFIDE

Common Name

English

Showing 1 to 5 of 12 entries

Previous1 2 3Next

Show entries

Classification Tree

Code System

Code

Established Pharmacologic Class

NDF-RT

N0000182830

Selective immunosuppressants

WHO-ATC

L04AA28

Immunotherapeutic Agent

NCI_THESAURUS

C574

HOST VS. GRAFT REACTION

EMA ASSESSMENT REPORTS

NULOJIX (AUTHORIZED: GRAFT REJECTION)

RENAL REPLACEMENT THERAPY

EMA ASSESSMENT REPORTS

NULOJIX (AUTHORIZED: KIDNEY TRANSPLANTATION)

Showing 1 to 5 of 7 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

NDF-RT

N0000182829

PRIMARY

T Lymphocyte Costimulation Activity Blockade [PE]

DRUG CENTRAL

5091

PRIMARY

USAN

QQ-105

PRIMARY

FDA UNII

E3B2GI648A

PRIMARY

RXCUI

1112973

PRIMARY

RxNorm

Showing 1 to 5 of 19 entries

Previous1 2 3 4Next

Subunit 0

Subunit 1

ACTIVE MOIETY


					E3B2GI648A

BELATACEPT